STOCK TITAN

Alvotech (NASDAQ: ALVO) discloses 2.7M-share intra-group transfer at $4.74

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

Alvotech filed a report describing an internal share transfer within a shareholder group closely associated with its CEO and chairman, Róbert Wessman. On January 30, 2026, ATP Holdings ehf. disposed of 2,701,617 Alvotech shares at USD 4.74 per share, while Aztiq Pharma Partners S.à r.l. acquired the same 2,701,617 shares at the same price. The company explains that ATP Holdings ehf. belongs to the Aztiq group, so the deal represents a transfer of shares within that group rather than a third‑party transaction. The report also notes that, excluding one exhibit, it is incorporated by reference into several existing Alvotech registration statements.

Positive

  • None.

Negative

  • None.
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of February 2026

Commission File Number: 001-41421

Alvotech
(Translation of registrant's name into English)

9, Rue de Bitbourg,
L-1273 Luxembourg,
Grand Duchy of Luxembourg

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F [ X ]      Form 40-F [   ]

 

 

 

 

 

Incorporation by Reference

 

This Report on Form 6-K (this “Report”) of Alvotech (the “Company”) excluding Exhibit 99.1 attached hereto, shall be deemed to be incorporated by reference into the Company’s registration statements on Forms F-3 (File Nos. 333-266136, 333-273262, 333-275111 and 333-281684), the Company’s registration statement on Form F-3ASR (File No. 333-289006), and the Company’s registration statement on Form S-8 (File No. 333-266881) and to be a part thereof from the date on which this Report is filed, to the extent not superseded by documents or reports subsequently filed or furnished.

 

Exhibits 99.1 and 99.2 to this Report are being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act.

 

Company Announcement

 

On February 27, 2026, Alvotech announced that according to forms filed the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) regarding transactions of managers and closely associated persons, ATP Holdings ehf. had announced the sale of 2,701,617 shares in Alvotech on January 30, 2026, and Aztiq Pharma Partners S.à r.l. ("Aztiq") announced the acquisition of 2,701,617 shares in Alvotech on January 30, 2026. The two announcements were related to the same transaction, and the transaction price was USD 4.74 per share. ATP Holdings ehf. belongs to the Aztiq group and the transaction was thus a transfer of shares within the group. Copies of the forms are furnished herewith as exhibits 99.1 and 99.2.

 

 

 

 

 

 

 

 

EXHIBIT INDEX

Exhibit Number Description
   
99.1 Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them (HOS-2 form)
   
99.2 Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them (HOS-2 form)

 

 

 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

      Alvotech    
  (Registrant)
   
  
Date: February 27, 2026     /s/ Tanya Zharov    
  Tanya Zharov
  General Counsel
  

 

 

 

 

 

 

 

 

 

Exhibit 99.1

 

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them (HOS-2 form)

 

Filing reference 13006
Submitted at 2026-02-11 19:01

 

1.    Details of the person discharging managerial responsibilities/person closely associated

 

Name1 ATP Holdings ehf.

 

2.Reason for the notification

 

Position/status2 Person closely associated to Róbert Wessman (CEO and chairman)
Initial notification/Amendment3 Initial notification

 

3.   Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

Name4 Alvotech
LEI5 222100DCZBOWV5DZ8372

 

4.   Details of the transaction(s): section to be repeated for 1 each type of instrument; 2 each type of transaction; 3 each date; and 4 each place where transactions have been conducted:

 

Description of the financial instrument, type of instrument6 Shares
Identification code7 LU2458332611
Nature of the transaction8 Disposal
Price(s) and volume(s)9 Price(s) Volume(s)
4.74 USD 2,701,617 (units)

Aggregated information

Aggregated volume10

Price11

 

2,701,617 (units)

4.74 USD

Date of the transaction12 2026-01-30
Place of transaction13 - XOFF

 

Date: 2026-02-11 19:01

 

 

Notes

1 For natural persons: the first name and the last name(s). For legal persons: full name including legal form as provided for in the register where it is incorporated, if applicable.

2 For persons discharging managerial responsibilities: the position occupied within the issuer, emission allowances market participant/auction platform/auctioneer/auction monitor should be indicated, e.g. CEO, CFO. For persons closely accociated:

An indication that the notification concerns a person closely associated with a person discharging managerial responsibilities;
Name and position of the relevant person discharging managerial responsibilities.

3 Indication that this is an initial notification or an amendment to prior notifications. In case of amendment, explain the error that this notification is amending.

4 Full name of the entity.

5 Legal Entity Identifier code in accordance with ISO 17442 LEI code.

6 Indication as to the nature of the instrument:

A share, a debt instrument, a derivative or a financial instrument linked to a share or a debt instrument;
An emission allowance, an auction product based on an emission allowance or a derivative relating to an emission allowance.

7 Instrument identification code as defined under Commission Delegated Regulation supplementing Regulation (EU) No 600/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the reporting of transactions to competent authorities adopted under Article 26 of Regulation (EU) No 600/2014.

8 Description of the transaction type using, where applicable, the type of transaction identified in Article 10 of the Commission Delegated Regulation (EU) 2016/522 adopted under Article 19(14) of Regulation (EU) No 596/2014 or a specific example set out in Article 19(7) of Regulation (EU) No 596/2014. Pursuant to Article 19(6)(e) of Regulation (EU) No 596/2014, it shall be indicated whether the transaction is linked to the exercise of a share option programme.

9 Where more than one transaction of the same nature (purchases, sales, lendings, borrows, ...) on the same financial instrument or emission allowance are executed on the same day and on the same place of transaction, prices and volumes of these transactions shall be reported in this field, in a two columns form as presented above, inserting as many lines as needed. Using the data standards for price and quantity, including where applicable the price currency and the quantity currency, as defined under Commission Delegated Regulation supplementing Regulation (EU) No 600/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the reporting of transactions to competent authorities adopted under Article 26 of Regulation (EU) No 600/2014.

10 The volumes of multiple transactions are aggregated when these transactions:

Relate to the same financial instrument or emission allowance;
Are of the same nature;
Are executed on the same day;
And are executed on the same place of transaction.

Using the data standard for quantity, including where applicable the quantity currency, as defined under Commission Delegated Regulation supplementing Regulation (EU) No 600/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the reporting of transactions to competent authorities adopted under Article 26 of Regulation (EU) No 600/2014.

11 Price information:

In case of a single transaction, the price of the single transaction;
In case the volumes of multiple transactions are aggregated: the weighted average price of the aggregated transactions.

Using the data standard for price, including where applicable the price currency, as defined under Commission Delegated Regulation supplementing Regulation (EU) No 600/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the reporting of transactions to competent authorities adopted under Article 26 of Regulation (EU) No 600/2014.

12 Date of the particular day of execution of the notified transaction. Using the ISO 8601 date format: YYYY-MM-DD; UTC time.

13 Name and code to identify the MiFID trading venue, the systematic internaliser or the organised trading platform outside of the Union where the transaction was executed as defined under Commission Delegated Regulation supplementing Regulation (EU) No 600/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the reporting of transactions to competent authorities adopted under Article 26 of Regulation (EU) No 600/2014, or if the transaction was not executed on any of the above mentioned venues, please mention "outside a trading venue".

 

 

 

Exhibit 99.2

 

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them (HOS-2 form)

 

Filing reference 13169
Submitted at 2026-02-26 15:12

 

1.    Details of the person discharging managerial responsibilities/person closely associated

 

Name1 Aztiq Pharma Partners S.à r.l.

 

2.Reason for the notification

 

Position/status2 Person closely associated to Róbert Wessman (CEO and chairman)
Initial notification/Amendment3 Initial notification

 

3.   Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

Name4 Alvotech
LEI5 222100DCZBOWV5DZ8372

 

4.   Details of the transaction(s): section to be repeated for 1 each type of instrument; 2 each type of transaction; 3 each date; and 4 each place where transactions have been conducted:

 

Description of the financial instrument, type of instrument6 Shares
Identification code7 LU2458332611
Nature of the transaction8

Acquisition

Intra-group from ATP Holdings ehf.

Price(s) and volume(s)9 Price(s) Volume(s)
4.74 USD 2,701,617 (units)

Aggregated information

Aggregated volume10

Price11

 

2,701,617 (units)

4.74 USD

Date of the transaction12 2026-01-30
Place of transaction13 - XOFF

 

Date: 2026-02-26 15:12

 

 

Notes

1 For natural persons: the first name and the last name(s). For legal persons: full name including legal form as provided for in the register where it is incorporated, if applicable.

2 For persons discharging managerial responsibilities: the position occupied within the issuer, emission allowances market participant/auction platform/auctioneer/auction monitor should be indicated, e.g. CEO, CFO. For persons closely accociated:

An indication that the notification concerns a person closely associated with a person discharging managerial responsibilities;
Name and position of the relevant person discharging managerial responsibilities.

3 Indication that this is an initial notification or an amendment to prior notifications. In case of amendment, explain the error that this notification is amending.

4 Full name of the entity.

5 Legal Entity Identifier code in accordance with ISO 17442 LEI code.

6 Indication as to the nature of the instrument:

A share, a debt instrument, a derivative or a financial instrument linked to a share or a debt instrument;
An emission allowance, an auction product based on an emission allowance or a derivative relating to an emission allowance.

7 Instrument identification code as defined under Commission Delegated Regulation supplementing Regulation (EU) No 600/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the reporting of transactions to competent authorities adopted under Article 26 of Regulation (EU) No 600/2014.

8 Description of the transaction type using, where applicable, the type of transaction identified in Article 10 of the Commission Delegated Regulation (EU) 2016/522 adopted under Article 19(14) of Regulation (EU) No 596/2014 or a specific example set out in Article 19(7) of Regulation (EU) No 596/2014. Pursuant to Article 19(6)(e) of Regulation (EU) No 596/2014, it shall be indicated whether the transaction is linked to the exercise of a share option programme.

9 Where more than one transaction of the same nature (purchases, sales, lendings, borrows, ...) on the same financial instrument or emission allowance are executed on the same day and on the same place of transaction, prices and volumes of these transactions shall be reported in this field, in a two columns form as presented above, inserting as many lines as needed. Using the data standards for price and quantity, including where applicable the price currency and the quantity currency, as defined under Commission Delegated Regulation supplementing Regulation (EU) No 600/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the reporting of transactions to competent authorities adopted under Article 26 of Regulation (EU) No 600/2014.

10 The volumes of multiple transactions are aggregated when these transactions:

Relate to the same financial instrument or emission allowance;
Are of the same nature;
Are executed on the same day;
And are executed on the same place of transaction.

Using the data standard for quantity, including where applicable the quantity currency, as defined under Commission Delegated Regulation supplementing Regulation (EU) No 600/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the reporting of transactions to competent authorities adopted under Article 26 of Regulation (EU) No 600/2014.

11 Price information:

In case of a single transaction, the price of the single transaction;
In case the volumes of multiple transactions are aggregated: the weighted average price of the aggregated transactions.

Using the data standard for price, including where applicable the price currency, as defined under Commission Delegated Regulation supplementing Regulation (EU) No 600/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the reporting of transactions to competent authorities adopted under Article 26 of Regulation (EU) No 600/2014.

12 Date of the particular day of execution of the notified transaction. Using the ISO 8601 date format: YYYY-MM-DD; UTC time.

13 Name and code to identify the MiFID trading venue, the systematic internaliser or the organised trading platform outside of the Union where the transaction was executed as defined under Commission Delegated Regulation supplementing Regulation (EU) No 600/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the reporting of transactions to competent authorities adopted under Article 26 of Regulation (EU) No 600/2014, or if the transaction was not executed on any of the above mentioned venues, please mention "outside a trading venue".

 

 

 

FAQ

What share transaction did Alvotech (ALVO) disclose in this Form 6-K?

Alvotech reported a January 30, 2026 transaction where ATP Holdings ehf. disposed of 2,701,617 Alvotech shares and Aztiq Pharma Partners S.à r.l. acquired the same number of shares at USD 4.74 each, reflecting an internal transfer within the Aztiq group.

Who were the parties involved in Alvotech’s 2,701,617-share transfer?

The transfer involved ATP Holdings ehf., which sold 2,701,617 Alvotech shares, and Aztiq Pharma Partners S.à r.l. (Aztiq), which acquired the same number. Alvotech states ATP Holdings ehf. belongs to the Aztiq group, making this an intra-group transfer within a shareholder group.

At what price were the Alvotech (ALVO) shares transferred on January 30, 2026?

The 2,701,617 Alvotech shares were transferred at a transaction price of USD 4.74 per share. Both the disposal by ATP Holdings ehf. and the acquisition by Aztiq Pharma Partners S.à r.l. occurred at this price on the same date and for the same volume.

How is this Alvotech share transfer related to the company’s CEO?

Both notifications describe the parties as persons closely associated with Róbert Wessman, Alvotech’s CEO and chairman. The filing notes that ATP Holdings ehf. belongs to the Aztiq group, so the transaction shifts shares within a group associated with the CEO rather than to outside investors.

Are the transaction forms in Alvotech’s 6-K considered filed or furnished?

The HOS-2 notification forms attached as Exhibits 99.1 and 99.2 are described as furnished rather than filed. They are not deemed filed for purposes of Section 18 of the Exchange Act and are not incorporated by reference into other Alvotech securities filings.

Does this Alvotech (ALVO) 6-K affect existing registration statements?

Alvotech states that this report, excluding Exhibit 99.1, is incorporated by reference into several existing registration statements on Forms F-3, F-3ASR, and S-8. This means the narrative information becomes part of those shelf and equity compensation registration documents.

Filing Exhibits & Attachments

2 documents
Alvotech

NASDAQ:ALVO

ALVO Rankings

ALVO Latest News

ALVO Latest SEC Filings

ALVO Stock Data

1.27B
117.87M
Drug Manufacturers - Specialty & Generic
Healthcare
Link
Luxembourg
Luxembourg City